Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2014-04, Vol.5 (4), p.282-283
Main Authors: Brazeau, Jean-Francois, Rosse, Gerard
Format: Article
Language:English
Subjects:
Patent Highlight
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a250f-7ee82e8531ba1bce1e2da6e68b21d4ef1e462832d217b0070b6b42700ba8d0083
cites
container_end_page 283
container_issue 4
container_start_page 282
container_title ACS medicinal chemistry letters
container_volume 5
creator Brazeau, Jean-Francois
Rosse, Gerard
description
doi_str_mv 10.1021/ml500052f
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4027772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1534102496</sourcerecordid><originalsourceid>FETCH-LOGICAL-a250f-7ee82e8531ba1bce1e2da6e68b21d4ef1e462832d217b0070b6b42700ba8d0083</originalsourceid><addsrcrecordid>eNptkMFKAzEQhoMotlYPvoDsRVBwdZImmy2CIFWrUPRSTyIh2Z21KdtNTbqF-vSutJYKnmZgPv75-Qg5pnBJgdGraSkAQLBih7Rpj6exSKXY3dpb5CCECUDSkxL2SYvxHkDKRJtcj7zVX650b_xCxPn7bOnt1Oa2wugOvV3ouV1giHSInqqxNXbufIhcEQ36z-yQ7BW6DHi0nh3y-nA_6j_Gw5fBU_92GGsmoIglYsowFV1qNDUZUmS5TjBJDaM5x4IiT1jaZTmj0gBIMInhTAIYneZNzW6H3KxyZ7WZYp5hNfe6VLOmqfZL5bRVfy-VHasPt1AcmJSSNQFn6wDvPmsMczW1IcOy1BW6OigqurwRyXtJg56v0My7EDwWmzcU1I9stZHdsCfbvTbkr90GOF0BOgtq4mpfNZr-CfoGyUiFWQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534102496</pqid></control><display><type>article</type><title>Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2</title><source>Open Access: PubMed Central</source><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Brazeau, Jean-Francois ; Rosse, Gerard</creator><creatorcontrib>Brazeau, Jean-Francois ; Rosse, Gerard</creatorcontrib><identifier>ISSN: 1948-5875</identifier><identifier>EISSN: 1948-5875</identifier><identifier>DOI: 10.1021/ml500052f</identifier><identifier>PMID: 24900825</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Patent Highlight</subject><ispartof>ACS medicinal chemistry letters, 2014-04, Vol.5 (4), p.282-283</ispartof><rights>Copyright © 2014 American Chemical Society</rights><rights>Copyright © 2014 American Chemical Society 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a250f-7ee82e8531ba1bce1e2da6e68b21d4ef1e462832d217b0070b6b42700ba8d0083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027772/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027772/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24900825$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brazeau, Jean-Francois</creatorcontrib><creatorcontrib>Rosse, Gerard</creatorcontrib><title>Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2</title><title>ACS medicinal chemistry letters</title><addtitle>ACS Med. Chem. Lett</addtitle><subject>Patent Highlight</subject><issn>1948-5875</issn><issn>1948-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNptkMFKAzEQhoMotlYPvoDsRVBwdZImmy2CIFWrUPRSTyIh2Z21KdtNTbqF-vSutJYKnmZgPv75-Qg5pnBJgdGraSkAQLBih7Rpj6exSKXY3dpb5CCECUDSkxL2SYvxHkDKRJtcj7zVX650b_xCxPn7bOnt1Oa2wugOvV3ouV1giHSInqqxNXbufIhcEQ36z-yQ7BW6DHi0nh3y-nA_6j_Gw5fBU_92GGsmoIglYsowFV1qNDUZUmS5TjBJDaM5x4IiT1jaZTmj0gBIMInhTAIYneZNzW6H3KxyZ7WZYp5hNfe6VLOmqfZL5bRVfy-VHasPt1AcmJSSNQFn6wDvPmsMczW1IcOy1BW6OigqurwRyXtJg56v0My7EDwWmzcU1I9stZHdsCfbvTbkr90GOF0BOgtq4mpfNZr-CfoGyUiFWQ</recordid><startdate>20140410</startdate><enddate>20140410</enddate><creator>Brazeau, Jean-Francois</creator><creator>Rosse, Gerard</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140410</creationdate><title>Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2</title><author>Brazeau, Jean-Francois ; Rosse, Gerard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a250f-7ee82e8531ba1bce1e2da6e68b21d4ef1e462832d217b0070b6b42700ba8d0083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Patent Highlight</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brazeau, Jean-Francois</creatorcontrib><creatorcontrib>Rosse, Gerard</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brazeau, Jean-Francois</au><au>Rosse, Gerard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2</atitle><jtitle>ACS medicinal chemistry letters</jtitle><addtitle>ACS Med. Chem. Lett</addtitle><date>2014-04-10</date><risdate>2014</risdate><volume>5</volume><issue>4</issue><spage>282</spage><epage>283</epage><pages>282-283</pages><issn>1948-5875</issn><eissn>1948-5875</eissn><cop>United States</cop><pub>American Chemical Society</pub><pmid>24900825</pmid><doi>10.1021/ml500052f</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-5875
ispartof ACS medicinal chemistry letters, 2014-04, Vol.5 (4), p.282-283
issn 1948-5875
1948-5875
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4027772
source Open Access: PubMed Central; American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Patent Highlight
title Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A18%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triazolo%5B4,5-d%5Dpyrimidine%20Derivatives%20as%20Inhibitors%20of%20GCN2&rft.jtitle=ACS%20medicinal%20chemistry%20letters&rft.au=Brazeau,%20Jean-Francois&rft.date=2014-04-10&rft.volume=5&rft.issue=4&rft.spage=282&rft.epage=283&rft.pages=282-283&rft.issn=1948-5875&rft.eissn=1948-5875&rft_id=info:doi/10.1021/ml500052f&rft_dat=%3Cproquest_pubme%3E1534102496%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a250f-7ee82e8531ba1bce1e2da6e68b21d4ef1e462832d217b0070b6b42700ba8d0083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1534102496&rft_id=info:pmid/24900825&rfr_iscdi=true